Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Goud

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Anesthesiology|March 8, 2022
Recent U.S. Food and Drug Administration Labeling Changes for Hydroxyethyl Starch Products Due to Concerns about Mortality, Kidney Injury, and Excess BleedingLaurence Landow, Shaokui Wei, Linye Song, et al.
Vaccine|May 19, 2021
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)Kerry J Welsh, Jane Baumblatt, Wambui Chege, et al.
Studies in Health Technology and Informatics|August 28, 2014
Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network AnalyzerTaxiarchis Botsis, John Scott, Ravi Goud, et al.
MMWR. Morbidity and Mortality Weekly Report|May 26, 2018
Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine - United States, 2017-2018Tom T Shimabukuro, Elaine R Miller, Raymond A Strikas, et al.
JAMIA Open|June 24, 2024
Using machine learning to improve anaphylaxis case identification in medical claims dataKamil Can Kural, Ilya Mazo, Mark Walderhaug, et al.
JAMIA Open|October 30, 2023
Using machine learning to improve anaphylaxis case identification in medical claims dataKamil Can Kural, Ilya Mazo, Mark Walderhaug, et al.
Vaccine|August 13, 2021
ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in MedicareRavi Goud, Deborah Thompson, Kerry Welsh, et al.
MMWR. Morbidity and Mortality Weekly Report|February 1, 2019
Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018Elisabeth M Hesse, Tom T Shimabukuro, John R Su, et al.
Journal of Biomedical Informatics|August 2, 2016
Decision support environment for medical product safety surveillanceTaxiarchis Botsis, Christopher Jankosky, Deepa Arya, et al.
JAMA Internal Medicine|November 1, 2021
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare BeneficiariesRavi Goud, Bradley Lufkin, Jonathan Duffy, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Anesthesiology|March 8, 2022
Recent U.S. Food and Drug Administration Labeling Changes for Hydroxyethyl Starch Products Due to Concerns about Mortality, Kidney Injury, and Excess BleedingLaurence Landow, Shaokui Wei, Linye Song, et al.
Vaccine|May 19, 2021
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)Kerry J Welsh, Jane Baumblatt, Wambui Chege, et al.
Studies in Health Technology and Informatics|August 28, 2014
Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network AnalyzerTaxiarchis Botsis, John Scott, Ravi Goud, et al.
MMWR. Morbidity and Mortality Weekly Report|May 26, 2018
Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine - United States, 2017-2018Tom T Shimabukuro, Elaine R Miller, Raymond A Strikas, et al.
JAMIA Open|June 24, 2024
Using machine learning to improve anaphylaxis case identification in medical claims dataKamil Can Kural, Ilya Mazo, Mark Walderhaug, et al.
JAMIA Open|October 30, 2023
Using machine learning to improve anaphylaxis case identification in medical claims dataKamil Can Kural, Ilya Mazo, Mark Walderhaug, et al.
Vaccine|August 13, 2021
ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in MedicareRavi Goud, Deborah Thompson, Kerry Welsh, et al.
MMWR. Morbidity and Mortality Weekly Report|February 1, 2019
Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018Elisabeth M Hesse, Tom T Shimabukuro, John R Su, et al.
Journal of Biomedical Informatics|August 2, 2016
Decision support environment for medical product safety surveillanceTaxiarchis Botsis, Christopher Jankosky, Deepa Arya, et al.
JAMA Internal Medicine|November 1, 2021
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare BeneficiariesRavi Goud, Bradley Lufkin, Jonathan Duffy, et al.
Pageof 1